lass ionomer cement (Ionocem) was developed for use in bone surgery and is reported to be notably biocompatible. Between 1991 and 1994 we performed revision operations for aseptic loosening of arthroplasties of the hip on 45 patients using this material in its granulate form (Ionogran) mixed with homologous bone as a bone substitute. Of these 45 patients, 42 were followed up for a mean of 42 months. Early reloosening of the acetabular component has occurred in ten after a mean of 30 months. Histological examination showed large deposits of aluminium in the adjacent connective tissue and bone. Osteoblastic function and bone mineralisation were clearly inhibited. The serum levels of aluminium were also increased. The toxic damage at the bone interface caused by high local levels of aluminium must be seen as an important factor in the high rate of early reloosening. Our findings cast doubt on the biocompatibility of this material and we do not recommend continuation of its further use in orthopaedic surgery.
The number of patients with loss of bone stock after revision arthroplasty for aseptic loosening is increasing. In most cases the condition is treated by grafting using homologous bone, but the amount available for this purpose is limited. The effort and cost involved in maintaining a bone bank and continuing uncertainty as to whether such graft will integrate successfully have stimulated a search for suitable substitutes for bone.
Long-term experience in dentistry with polymaleic ionomers suggested that they might be a suitable material. These so-called glass ionomer cements were first developed in 1969 by Wilson et al. 1 Chemically, the material is an ionic polymer and a compound of a calcium fluoro-aluminosilicate glass (G 200) and polycarboxylic acid. The hardened glass ionomer cement (GIC) is an aqueous phase of aluminium and calcium polycarboxylate in which the original glass particles are embedded. 1, 2 Initially, this material was used exclusively in dentistry to treat dental caries. It was resistant to aqueous or acid attack and had good adhesion to dental structures. After numerous biological tests most authors reported that it had good biological compatibility. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Disturbed mineralisation and pulp necrosis observed in some cases were attributed to the release of cytotoxic substances, and recently there have been reports of poor results with its use in dentistry. [14] [15] [16] [17] [18] [19] [20] In 1994 Anderson discussed the detectable release of aluminium as a triggering agent, while release of fluoride was seen mainly as a positive factor because of its cariostatic effect on tooth decay. 10, [21] [22] [23] [24] [25] [26] As a result of the good dental results, a polymaleic ionomer (Ionocem) was developed for use in bone surgery. It is produced by neutralisation of an aqueous solution of polycarboxylic acid. Compared with acrylic cements its advantages are that there are no unphysiologically high setting temperatures and no release of toxic monomers or initiators. 27, 28 Ionocem cement is produced by mixing the powder and liquid components. The material is also available as a finished product in the form of granules known as Ionogran. There are two sizes of granule, 0.5 to 1.0 mm and 2.0 to 5.0 mm. The granules have both micropores (1 to 10 µm) and macropores (100 to 600 µm). This high degree of porosity gives them a large surface area of approximately 70 ± 10 m 2 /g. 29 In the mid-1980s extensive animal experiments by Jonck gave positive results which led to the clinical use of this material in orthopaedic surgery for the fixation of hip and knee prostheses and for closing large bone defects. [30] [31] [32] [33] Failures occurring after fixation of prostheses with Ionocem were attributed to technical reasons and to infection. No local or general complications were observed after bone defects had been closed using Ionogran (Lindeque, personal communication) . In the late 1980s the cement was widely used for grafting in rhinology and also neurosurgery. Opinions on the results were mainly favourable. [34] [35] [36] [37] [38] [39] [40] Not until 1994 did studies reveal the alarming side-effect of the release of aluminium. Two patients developed encephalopathy after direct contact of the glass ionomer cement with spinal fluid which resulted in symptoms similar to those of Alzheimer's disease. 41 In 1996 a case of encephalopathy was reported after a petrous bone defect had been filled with Ionocem. 42 Since then, otorhinolaryngologists have been aware that there is a possibility of the neurotoxic release of aluminium when GIC is used and that special risks are involved when the cement has direct contact with CSF and nerve tissue. 43 Because of these results and new histological findings, at the end of 1994 the first author discontinued the use of this material as cement in exchange arthroplasty operations. We now describe these clinical and morphological results.
Patients and Methods
Between November 1991 and December 1994 we participated in a multicentre study to test GIC in its granular form (Ionogran; ESPE GmbH & Co KG, Seefeld, Germany). It was used to reconstruct bone defects in 45 patients with aseptic loosening. Its apparent advantages were that: 1) it was reported to be very biocompatible; 2) it was easy to apply; 3) it could be resterilised; 4) it could also be mixed with finely ground autologous or homologous cancellous bone thus producing a larger and at the same time more stable quantity of graft material; and 5) it was less expensive than other comparable materials. There were 38 women and seven men with a mean age at operation of 69.3 years (43 to 85). Three have since died from unrelated causes. The remaining 42 patients have been followed up for a mean of 42.3 months (15 to 64).
The diagnoses for primary arthroplasty were: coxarthrosis (28) , dysplastic coxarthrosis (8), trauma (6), postinfectious coxarthrosis (2) and rheumatoid arthritis (1) . The mean period between the last operation and the exchange procedure was 12.8 years (3 to 25). Two of the patients had undergone two previous operations for aseptic loosening, six had one operation, and two had one operation for septic loosening. Of the 45 prostheses, 39 were cemented and six uncemented. Operative technique. We carried out the operations in our normal way using a posterior approach. The Ionogran granules were mixed with an equal volume of finely ground homologous cancellous bone and were used to replace lost bone stock in closed cavities only. Defects of the acetabular rim or cortex were reconstructed using other appropriate grafting techniques. The standard modular system and revision designs of the ENDO-Modell prosthesis (Waldemar Link GmbH & Co, Hamburg, Germany) were used in all cases. 44, 45 After the defects had been filled, the components were cemented using Refobacin-Palacos cement (Merck, Darmstadt, Germany) according to the method of Sloof which we have used routinely since 1983 when reconstructing bone defects with homologous cancellous bone only. 44, [46] [47] [48] [49] When bone defects in closed cavities were filled with maximum compression of the graft, the mixture of cancellous bone and Ionogran resulted in better primary stability than when finely ground cancellous bone alone was used.
A large number of special cups and stems were used in reconstruction and bone grafting because most of the patients had loss of bone stock of grade II or grade III (Table I) . 44 The mean quantity of granules mixed with cancellous bone was 11.2 g (5 to 30) for the acetabulum and 10.35 g (5 to 15) for the femur. Around the rim of the acetabulum and the proximal shaft, exposed areas of the granule mixture were carefully covered with bone cement to prevent granules from penetrating between the surfaces of the prosthetic components.
Tissue samples were taken from the capsule and the implant-bone interface and samples of bone were sent for histomorphological examination. In six patients the levels of serum aluminium were also measured.
Results
Early postoperative complications. We did not observe any postoperative reaction to the implanted material. Complications unrelated to the prosthesis were minor and were treated conservatively (Table II) . In one patient, early recurrent dislocation occurred because of severe deficiency of the abductor muscles after many previous operations. Four months after the exchange operation further surgery was necessary to correct this. At this time there were no unusual intraoperative findings and no visible toxic reactions or loosening of the components were observed. The hip was treated by an antidislocation ring and insertion of a stem component with an extra-long femoral head. One year later there was reloosening of the cup and both components were exchanged to eliminate the Ionogran from the shaft.
One patient had a fracture of the femur at the top of the stem without dislocation and was treated conservatively; there were no further complications.
Superficial infection of the sutures which resolved completely after local treatment was seen in one patient; no deep infections occurred (Table II) . Aseptic reloosening. Until the end of the study in late 1994 all patients remained free from complications. The early postoperative control radiographs showed no unusual features. In particular, there were no signs of radiolucency in the distal region of the acetabular component (which corresponds to type III of DeLee and Charnley), such as we have observed in about 70% of cases in which finely ground homologous cancellous bone alone was used. This radiolucency is due to minimal migration of the component following condensation of the graft material after the first weight-bearing activities of the patient. We interpreted the absence of this phenomenon in the Ionogran cases as a sign of better primary stability. The first reloosening of a cup occurred three years after operation and this was seen in ten patients by the end of 1996. The mean period between revision and reloosening was 30 months (15 to 50).
In four patients the onset of pain on weight-bearing was followed by rapid and extensive loss of bone which required immediate surgical correction (Fig. 1) . Macroscopically, the changes seen at the site of the operation were similar to those usually observed with loose prostheses. However, all the samples of puncture fluid aspirated during the preoperative examination to detect the presence of infection were cloudy. In two patients exceptionally large amounts of this fluid were removed. Examination revealed no evidence of infection and the consistency was due to the large quantity of protein in the fluid. We have not observed such findings in any of the cases in which we have used only cancellous bone to fill bone defects, or in any of the 60 patients whom we have followed up over the last five years in a parallel study in which a mixture of homologous cancellous bone and hydroxyapatite granules has been used and the components fixed with cement. [47] [48] [49] [50] In seven of the ten patients with loose prostheses further revision was necessary. The defects in the bone stock were treated by grafting with homologous cancellous bone and implantation of a special acetabular component. In two, defects in the acetabular roof were closed using supporting screws and cementing an extra-large support cup. In four patients the acetabulum had to be stabilised by a Kerboul plate. In one of these, additional grafts with homologous bone were used to close the defects and in three autologous bone was taken from the ipsilateral iliac crest. So far, reloosening of the femoral component has not occurred. In two patients, in whom an exchange of the acetabular component was required, we exchanged the stem to eliminate the Ionogran although the component was firmly fixed. Macroscopically, there were no signs of toxic reaction at the interface, but the grafted mixture of Ionogran and homologous cancellous bone showed no signs of bony integration, and most of it could be curetted out of the cavity as an amorphous mass. The components were refixed using standard cement only (Table III) . Histological findings Interface material. The acetabular material showed largely identical changes in all seven revised cases. There were remains of the implanted cancellous bone and particles of GIC in hyalinised tissue. Osteoclasts were found on the surface. No osteoblasts were seen, which is unusual in aseptic loosening. The osteoid was clearly increased and in places also widened. Specific staining for aluminium showed extensive deposits in the mineralisation front of the osteoid of the originally implanted cancellous bone and the adjacent newly-formed bone tissue. The implanted cancellous particles were dead and in some parts impregnated to a remarkable degree with aluminium. The GI particles showed the most intensive staining. In the connective tissue there were numerous macrophages with aluminium particles in the cytoplasm. No inflammatory reaction was detected in any of the cases examined. Macrophages showed distinct staining when treated with the macrophage marker CD68. There was no newly-formed bone on the GIC (Figs  2 and 3) . Bone biopsies. In three cases samples of autologous bone were taken from the ipsilateral iliac crest in order to detect possible deposits of aluminium in the skeleton at sites remote from the local process. There were deposits in the macrophages in the bone marrow in one case, but osteomalacia as a result of disturbed mineralisation induced by aluminium was not seen. No pathological deposits of aluminium were found in the mineralisation front of the osteoid (Fig. 4) . Serum aluminium levels. In the six patients examined, the acetabular component was loose in three and in the other three it was still firmly fixed. In all, an increase in the level of serum aluminium was found, with mean values ranging from 30 to 70 µg/l. In one patient with very severe loosening and a remarkably extreme intraoperative toxic reaction with massive exudate in the joint, the preoperative value was 115.9 µg/l and in the early postoperative phase after a further exchange operation it was 97.8 µg/l. In another patient who had had a second revision the preoperative value rose from 56.9 µg/l to 172.2 µg/l in the early postoperative phase, and after four months it had fallen to 59. antacids or during dialysis. 51, 52 The release of aluminium depends on the pH value and is directly proportional to the surface area of the material. 39 In patients with loosened prostheses the amount released seems to be higher which may be explained by the damage caused by loosening, leading to further enlargement of the already very large surface of the material, together with alteration of the pH value. Although the values for serum aluminium mostly remained within a range which would not necessarily require treatment with desferrioxamine, 52 the consequences of this situation are unforeseeable and we therefore believe that glass ionomer cement should no longer be used as a biomaterial. Chronic high concentrations of aluminium and the resulting inhibition of bone mineralisation can lead to general osteoporosis with an increased risk of fracture and unfavourable conditions for the implantation of prostheses. 53 Earlier reports suggested that this was a useful biomaterial with many beneficial applications but the longterm effects of continuous release of aluminium were largely ignored. As late as 1996 Claes et al and other authors [54] [55] [56] [57] were still carrying out measurements of the mechanical properties of GIC on the assumption that the lack of cytotoxic phenomena made this material especially suitable for use in arthroplasty. The positive clinical reports on the use of these granules to close bone defects caused by loss of bone stock and tumour resection may be because, unlike when used in the hip, the implanted material was not under dynamic load. 29 Bone mineralisation and osteoblasts are inhibited by a high local level of aluminium. [58] [59] [60] [61] [62] Experimental studies and observations of the influence of aluminium on the skeletal system of birds and the composition of eggshells, have revealed that increased concentrations of aluminium in bird feed interfere with phosphorus metabolism and lead to defective mineralisation of the shells. This results in detrimental effects on growth and bone mass, and the frequency of egg production is decreased. [63] [64] [65] In the seven patients whom we have examined, osseointegration of the implanted autologous cancellous bone did not take place after loosening had occurred. In the patient with very severe loosening, the systemic concentrations of aluminium were so high that deposits were present in the macrophages of the bone marrow, but not in the bone itself. The same pattern of deposition of aluminium in macrophages only has been observed in 10% of patients on long-term dialysis. Encephalopathy did not occur, however, in patients with renal osteopathy and aluminium in macrophages alone 51 and our patients have so far shown no clinical signs of encephalopathy. 51, 62, 66 Therefore we feel justified in our opinion that additional treatment with desferrioxamine is not necessary in the patients in whom the GIC has been removed after loosening has occurred. Increased levels of serum aluminium of 33 to 70 µg/l (normal range, 6 to 30/ µgl) were also found in patients without loosening of the implant but not sufficient to require treatment with desferrioxamine or an exchange operation. Intensive follow-up of these patients is, however, mandatory and if reloosening should occur, the whole prosthesis should be exchanged and the granules removed completely.
Local deposits of aluminium produce effects similar to those seen in severe renal bone disease. Aluminium is deposited in the mineralisation front of the osteoid and this process becomes disturbed, as observed in cases of osteomalacia. 67 Mineralisation of the cancellous bone is blocked by deposits of aluminium. We are uncertain as to the outcome in the patient with high serum levels of aluminium in whom deposits were found in the macrophages of the bone marrow remote from the location of the implanted material. The measured levels show that the risk of encephalopathy is low, 62, 68 but it is as yet not possible to assess the severity of the effect of overloading the human body with aluminium. Aluminium is still used today in implant materials and is considered to be biocompatible, especially in the form of alumina and special titanium alloys. The development of macrophages and osteoclasts as a result of wear particles generated from the surface of loosened joint prostheses is thought to be one of the most important causes of osteolysis. 69 In 1997 we observed a marked increase in the serum aluminium concentration in a patient with a loosened hip prosthesis and extensive metallosis after excessive wear of a titanium femoral head. We suggest that titanium alloys should be subjected to surface treatment such as nitriding which will enhance the resistance of the implant to wear. [70] [71] [72] It is difficult to find an explanation as to why, so far, only acetabular components have become loose. The reconstructive procedures on the femur were performed with maximum pressurisation of the GIC and homologous cancellous bone which may have achieved better primary stability. Intraoperative and radiological observations suggest that Ionogran usually results in greater primary stability compared with finely ground homologous cancellous bone used alone. Theoretically, weight-bearing may cause microfractures of the granules which could cause an increased release of aluminium leading to toxic damage of local tissue. In our experience with homologous bone in revision arthroplasty we have not observed such acute early loosening. In a follow-up study of 447 patients treated between 1983 and 1985, in whom homologous cancellous bone only was used to reconstruct bone defects of all grades, the rate of reloosening after four years was less than 5% and after eight years only 7%. We attribute the extremely high rate of loosening of 22% after only 3.5 years in this series to the toxic release of aluminium and the development of high local concentrations of this element in the surrounding tissue. [46] [47] [48] [49] We do not recommend continuation of the use of this material in orthopaedic surgery.
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